ANXA1 and neoplasm: In addition to regulating membrane trafficking, proliferation, differentiation, and apoptosis [9,10,11,12], AnxA1 inhibits Phospholipase A2 (PLA2) in the cytoplasm [13,14] and impedes the release of arachidonic acid, which is a key contributor to the development of the tumor microenvironment (TME).